Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

The latest erectile dysfunction medication to hit the market is being launched today by UKMedix, the famous UK internet retailer.

UKMedix predict the Orodispersible form of Levitra will lead to a substantial increase in the popularity of the medication as a treatment for erectile dysfunction and will boost market share for Bayer over the extremely popular Viagra and Cialis rivals.

Over the last two years UKMedix has seen incredible growth in the erectile dysfunction market, which European Marketing Manager Tom Bailey puts down to the fantastic customer service program which UKMedix offer to their patients.

Tom predicts that having Levitra in Orodispersible form will lead to an even greater share of the E.D. market for UKMedix.

“We have always strived to keep to our goals of “Great Service at a Great Price” and we intend to do the same with Levitra Orodispersible. We also believe that the melt in your mouth option for Levitra will open the E.D. market up to a new demographic.” He explains, “there are a large number of men so embarrassed about having to take medication to achieve or maintain an erection that this new method of delivery will have the added benefit of total discretion.”

In The Press

Following the recent article in the Daily Mail regarding Levitra Orodispersible more stories have popped up all over the web.

UKMedix news has reported that Pfizer may be launching a chewable form of Viagra in the near future.

These new forms of E.D. medication may herald a new and exciting era for the millions of men who suffer from E.D. worldwide.

UKMedix leading the way

One of the first retailers to offer you Levitra Orodispersible, Ukmedix offers unrivalled features such as UKMedix price scan and free 24/7 access to the UKMedix Medical Team.

This press release was distributed by ResponseSource Press Release Wire on behalf of UKMedix in the following categories: Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.